SELPLG and HIV infectious disease: Since sCD40L and glutamate have been proven to be effective at inducing PSGL-1 expression on monocytes (104), an approach targeting PSGL-1 using these factors during HIV infection could be a viable alternative approach to the treatment of CVDs and neurocognitive disease.